> ## Content Index
> Fetch the complete content index at: https://acentricresearch.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# In-space biomanufacturing (stem cells, organoids, tissue): Junction Brief – November 2026
- URL: https://acentricresearch.com/research/in-space-biomanufacturing-brief-2026-11/
- Published: 2026-11-21T09:29:14.000Z
- Updated: 2026-11-21T09:29:14.000Z
- Author: Kevin Meyer
- Tags: biotechnology-space, junction-brief

> Acentric Research is produced with AI tools under human review. The authors are not financial professionals, and nothing here is investment advice or a recommendation to buy or sell any security. AI analysis can be wrong; check every claim against its cited source.

This Brief is an initial scan, not a full investigation. The method and scores behind it are in [Biotechnology × Space in the Landscape Report](https://acentricresearch.com/research/landscape-2026-11/#biotechnology-space).

### Overview

Researchers want to know whether cells and tissue grown in microgravity can be made better or in new ways than on Earth. The ISS National Laboratory says cells in microgravity form complex three-dimensional structures that more closely resemble tissue in the body, and names uses in disease modelling, drug development, regenerative medicine and wound healing. \[1\] An organoid is a three-dimensional clump of cells, under 1 millimetre across, that mimics part of an organ. \[2\]\[3\]

In the sources opened, these are research flights by a hospital system and a non-profit, with agency awards, and not production. Cedars-Sinai said in August 2025 that it aimed to create the first heart and brain organoids made in space, on its sixth mission to the International Space Station (ISS). \[2\] The sources opened show no cell or tissue product made in space for use in patients, and the outcomes of the 2025 flights were not searched for. The dated sources run from 2021 to 2025, and later developments were not searched, apart from a newsroom headline that lists a seventh Cedars-Sinai flight in October 2026\. \[4\]

### Current state

**What the technology does.** Cells are launched (Cedars-Sinai's were frozen for the trip), cared for by astronauts, photographed through microscopes, and returned to Earth after about a month for analysis of size, shape and genetics. \[2\] Cedars-Sinai says heart organoids can be used to study the effects of cancer therapies on the heart and to test heart therapies, and brain organoids to model neurodegenerative diseases such as ALS, Huntington's disease and Parkinson's disease. \[2\] The investigators say gravity compresses organoids on Earth, and that they believe organoids will grow better in microgravity, perhaps forming blood vessels or cell types that do not develop on Earth. These are expectations, not results. \[2\]

**Who is working on it.** In 2021 the ISS National Laboratory issued a research announcement for in-space biomanufacturing for regenerative medicine, with suggested topics of stem-cell expansion, organoid culture to model disease or test treatments, and in-space fabrication of tissue; funding covered mission integration and operations costs. \[5\] The 2021 announcement used a two-step process, with concept summaries due 22 November 2021 and full proposals due 14 February 2022; awards were to be brokered by the organization that manages the Laboratory. \[5\] Cedars-Sinai's August 2025 release says its experiment was the third funded through a NASA In-Space Manufacturing Award, in partnership with Axiom Space, and lists earlier firsts including introducing DNA into stem cells in space, using off-the-shelf laboratory hardware for space research, and producing stem cells in space. Its cells came from the Allen Institute for Cell Science and flew in a plate habitat made by BioServe Space Technologies. \[2\] The National Stem Cell Foundation says it has flown six missions since 2019 carrying brain organoids made from the cells of people with Parkinson's disease and primary progressive multiple sclerosis, and describes its culture method as patent-pending and says findings were published in *Stem Cells Translational Medicine* (the foundation's claims; the paper was not opened). \[3\]

**How far it has come.** Early research flights. Organoids and stem cells have flown and returned for study. No result showing better cells or tissue than Earth methods, and no therapy made in space, appears in the sources opened. \[2\]\[3\]

### Opportunities

The Cedars-Sinai lead investigator says the hope is a lab in space that works alongside labs on Earth, opening the way to bioprinting of artificial heart, brain and muscle tissue in space. \[2\] The National Stem Cell Foundation says NASA's award will fund another three ISS missions through 2027, including organoids from people with Alzheimer's disease. \[3\] The ISS National Laboratory's announcement says targeted fields such as tissue engineering show how sponsored research may lead to new biological products and tools and a sustainable market in low Earth orbit. \[5\] The Laboratory also names organ growth to address the shortage of transplant organs as a possible use of tissue engineering in microgravity. \[1\]

### Challenges

- **Physics and engineering.** The organoids flown are under 1 millimetre across, and the Cedars-Sinai samples return after about a month for analysis. \[2\] The sources opened do not describe producing cells in clinical quantities.
- **Capital and scale-up.** NASA's award to the National Stem Cell Foundation is $3.1 million, with a $300,000 match from the Commonwealth of Kentucky, for ground research and three missions. \[3\]

### Data sources

- **ISS National Laboratory programme pages and project portfolio**, for flights and funded projects. \[1\]\[6\]
- **NIH RePORTER**, for federal grants such as the one Cedars-Sinai says funds its organ-chip work. \[7\]\[2\]
- **ClinicalTrials.gov**, for any clinical study of cells or tissue linked to a space experiment. \[8\]
- **Institution and foundation releases**, which carry most of the detail on flights.
- No registry of in-space cell experiments and their outcomes was found.

### Changelog

- 2026-11-18: First published.

### Sources

1. ISS National Laboratory, "In-Space Production Applications" (programme page, undated; statements about the programme and about microgravity research are the Laboratory's). [issnationallab.org](https://issnationallab.org/?p=34469&ref=acentricresearch.com) (accessed 2026-11-18)
2. Cedars-Sinai, "Cedars-Sinai Pioneering Creation of Organoids in Space", 2025-08-18 (institution release; statements about expected benefits are the investigators'). [cedars-sinai.org](https://www.cedars-sinai.org/newsroom/cedars-sinai-pioneering-creation-of-organoids-in-space/?ref=acentricresearch.com) (accessed 2026-11-18)
3. SatNews, "NASA awards National Stem Cell Foundation $3.1 million to continue studying the effects of microgravity on brain cells", 2025-03-27 (trade site reproducing the foundation's announcement; statements and claims are the foundation's). [news.satnews.com](https://news.satnews.com/2025/03/27/nasa-awards-national-stem-cell-foundation-3-1-million-to-continue-studying-the-effects-of-microgravity-on-brain-cells?ref=acentricresearch.com) (accessed 2026-11-18)
4. Cedars-Sinai newsroom, headline excerpt "Cedars-Sinai Sends New Stem Cell Experiments to Space", 2026-10-15, shown in the sidebar of the same page (the release behind that headline was not opened). [cedars-sinai.org](https://www.cedars-sinai.org/newsroom/cedars-sinai-pioneering-creation-of-organoids-in-space/?ref=acentricresearch.com) (accessed 2026-11-18)
5. ISS National Laboratory, "ISS National Lab Releases Research Announcement Focused on In-Space Production Applications in Biomanufacturing", 2021-10-20 (programme release). [issnationallab.org](https://issnationallab.org/iss360/insp-biomanufacturing-nlra-announcement/?ref=acentricresearch.com) (accessed 2026-11-18)
6. ISS National Laboratory, research project portfolio. [issnationallab.org](https://issnationallab.org/?ref=acentricresearch.com) (listed as a data source; the portfolio itself was not opened for this Brief)
7. NIH RePORTER, project search. [reporter.nih.gov](https://reporter.nih.gov/?ref=acentricresearch.com) (listed as a data source; not opened for this Brief)
8. ClinicalTrials.gov, study search. [clinicaltrials.gov](https://clinicaltrials.gov/?ref=acentricresearch.com) (listed as a data source; not searched for this Brief)